Nephros Inc
NASDAQ:NEPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DT Cloud Star Acquisition Corp
NASDAQ:DTSQ
|
US |
|
T
|
Tlou Energy Ltd
LSE:TLOU
|
AU |
|
C
|
Consensus Cloud Solutions Inc
NASDAQ:CCSI
|
US |
|
AssetMark Financial Holdings Inc
NYSE:AMK
|
US |
|
Q
|
Quest Softech (India) Ltd
BSE:535719
|
IN |
|
J
|
Jubilee Gold Exploration Ltd
XTSX:JUB
|
CA |
Nephros Inc
Inventory
Nephros Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nephros Inc
NASDAQ:NEPH
|
Inventory
$3.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
19%
|
|
|
Whirlpool Corp
NYSE:WHR
|
Inventory
$2.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
Hamilton Beach Brands Holding Co
NYSE:HBB
|
Inventory
$133.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Cricut Inc
NASDAQ:CRCT
|
Inventory
$102.7m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Vesync Co Ltd
HKEX:2148
|
Inventory
$72.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sharkninja Inc
NYSE:SN
|
Inventory
$1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nephros Inc
Glance View
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.
See Also
What is Nephros Inc's Inventory?
Inventory
3.2m
USD
Based on the financial report for Dec 31, 2025, Nephros Inc's Inventory amounts to 3.2m USD.
What is Nephros Inc's Inventory growth rate?
Inventory CAGR 10Y
19%
Over the last year, the Inventory growth was 24%. The average annual Inventory growth rates for Nephros Inc have been 1% over the past three years , -9% over the past five years , and 19% over the past ten years .
